Overview of Iodomarin 200

Property	Description
Active ingredient	Potassium Iodide (INN)
Form	Tablet (Oral administration)
Pharmacological class	Iodine preparation / Trace element preparation
General purpose	Prophylaxis of iodine deficiency and related conditions
Origin	Synthetic inorganic salt

Iodomarin 200: Definition and Classification as an Iodine Preparation

Iodomarin 200 is defined as a specific medicinal preparation—not merely a food supplement—and is classified as both an iodine preparation and a trace element preparation. This product, administered in the tablet dosage form, is fundamentally designed to provide a consistent external source of the essential micronutrient element, iodine, which the body cannot produce itself. Its classification places it within the pharmacological group of Thyroid hormone synthesis regulators, indicating its primary role is supplying the necessary raw material for the natural production of the body's hormones. The primary function of iodine is its role as an essential component of the thyroid hormones; it is recognized that adequate iodine intake is critical for proper thyroid function throughout life.

Active Composition: What is Potassium Iodide in Iodomarin 200?

The active pharmaceutical ingredient in Iodomarin 200 is Potassium Iodide (INN), a synthetic inorganic salt. This compound rapidly dissociates following ingestion, releasing the biologically active component, the Iodide ion (I^-). Iodomarin 200 is a monopreparation, meaning it contains only this single active ingredient, allowing for the precise and quantifiable delivery of the micronutrient. The numerical designation "200" specifically refers to the amount of the active substance or its equivalent in the tablet dosage unit, ensuring a standardized supply. Potassium Iodide is the preferred chemical form for providing standardized iodine supplementation due to its stability and high bioavailability.

General Purpose: Why is Iodomarin 200 Considered a Prophylactic Agent?

The general purpose of Iodomarin 200 is to function as a prophylactic agent by ensuring adequate iodine supply, a component critical for the endocrine system. The preparation’s action facilitates the necessary substrate for the thyroid gland to synthesize its own thyroid hormones, thyroxine (T4) and triiodothyronine (T3). This formulation is clinically recognized for its reliability in correcting dietary gaps. By maintaining sufficient hormone synthesis, Iodomarin 200 helps to preserve normal metabolic function and prevent the development of conditions associated with iodine insufficiency, such as the enlargement of the thyroid gland known as goiter.

What side effects are possible with Iodomarin 200?

Possible Side Effects and Safety Information

The official safety profile for this iodine preparation, based on regulatory documentation, primarily focuses on potential effects related to the endocrine system and immune function.

Adverse Reactions Classified by Frequency

Adverse reactions are generally infrequent at prophylactic doses, but the following classifications are provided in regulatory texts:

Classification	Examples of Documented Adverse Reactions
Rare (1 to 10 in 10,000 users)	Iodine-induced hyperthyroidism, Hypersensitivity reactions (e.g., skin rash, local swelling).
Very Rare (Fewer than 1 in 10,000 users)	Severe hypersensitivity reactions, such as Angioedema (swelling of the face, throat, or tongue).
Not Known	Iodine-induced goiter and hypothyroidism (observed particularly when high doses are given to susceptible individuals).

System-Organ Classes and Other Effects

The documented adverse effects are classified within several System-Organ Classes, including Endocrine Disorders and Immune System Disorders. A collection of symptoms known as Iodism may occur, typically associated with higher levels of iodine exposure. Symptoms of Iodism can include a metallic taste in the mouth, sore gums, and stomach upset.

Population-Specific Safety Considerations

The risk of developing iodine-induced hyperthyroidism is noted in official safety information to be higher in older patients and individuals with autonomously functioning regions of the thyroid gland. Furthermore, use is strictly contraindicated in cases of manifest hyperthyroidism, toxic thyroid adenoma, and Duhring's disease.

Safety notes also indicate that high doses in pregnant women may lead to goiter and hypothyroidism in the newborn. The risk of certain adverse effects is linked to prolonged high-dose exposure in susceptible individuals, as defined in regulatory warnings.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information describes overdose for Iodomarin 200 (Potassium Iodide) based on two main types of toxicity: chronic poisoning and acute sensitivity.

Documented Overdose Manifestations

Chronic exposure to high doses of iodide may lead to a condition known as Iodism. Documented manifestations include a metallic taste, severe headache, soreness of the teeth and gums, and a burning sensation in the mouth or throat. Skin-related signs like acneform lesions and, in rare instances, severe skin eruptions are also noted.

Severe Outcomes and Required Actions

Acute sensitivity to iodide or an excessive dose can result in severe outcomes, such as Angioedema (swelling beneath the skin) and Laryngeal Edema (swelling of the voice box). Official regulatory documents specify that the occurrence of severe shortness of breath requires immediate medical attention.

Overdose Management Action	Official Regulatory Instruction
Drug Discontinuation	The drug must be withdrawn (discontinued) if symptoms of Iodism appear.
Supportive Measures	Abundant fluid and salt intake is required, as it aids in the elimination of iodide.
Antidote	No specific antidote is documented in regulatory prescribing information.

Population-Specific Considerations

For infants under one month of age, special caution is advised; medical follow-up may be necessary if more than a single dose is administered, due to potential concerns regarding normal development.

Therapeutic Uses of Iodomarin 200

Main Uses and Therapeutic Focus

Iodomarin 200 is a medication designed to provide the body with inorganic iodine, an essential trace element required for the physiological function of the thyroid gland. Its primary therapeutic roles include the prevention of iodine deficiency disorders and the management of specific non-malignant thyroid conditions.

Prevention of Iodine Deficiency

The most common use of Iodomarin 200 is to prevent the development of goiter—an enlargement of the thyroid gland—in regions where iodine intake from food and water is insufficient. It is used as a preventive measure in individuals with increased nutritional requirements for iodine, such as children, adolescents, and young adults.

Treatment of Euthyroid Goiter

Iodomarin 200 is indicated for the treatment of diffuse euthyroid goiter. This is a condition where the thyroid gland is enlarged but continues to produce a normal amount of thyroid hormones. In such cases, the administration of iodine helps to normalize the size of the gland or prevent its further enlargement by satisfying the underlying physiological demand for the mineral.

Biological Benefits of Iodine Supplementation

Iodine is a fundamental component of the thyroid hormones thyroxine (T4) and triiodothyronine (T3). These hormones are critical for numerous body processes, including:

Metabolic Regulation: Maintaining the rate at which the body utilizes energy.
Growth and Development: Supporting the physical and mental development of children and adolescents.
Organ Function: Influencing the proper functioning of the brain, heart, and muscles.

By ensuring adequate iodine levels, Iodomarin 200 helps maintain the structural integrity and functional efficiency of the thyroid system.

Regulatory References

NIH Office of Dietary Supplements guidance on Iodine

Eligibility and Restrictions for Use

Iodomarin 200 (potassium iodide) is primarily used to prevent and treat iodine deficiency disorders (IDD), such as endemic goiter, in various populations. This includes its use for the prevention of IDD in:

Children and adolescents
Adults
Pregnant and breastfeeding women, who have increased iodine requirements

It is also indicated for the treatment of diffuse non-toxic and euthyroid goiter in children (including newborns) and adults.

Contraindications and Cautions

Iodomarin 200 should not be used in individuals with a known hypersensitivity or allergy to iodine or any of the product's other ingredients. Use is generally contraindicated in the following conditions:

Overt hyperthyroidism (overactive thyroid)
Latent hyperthyroidism (subclinical overactive thyroid), if the recommended daily dose exceeds 150 mu g
Autonomous thyroid adenoma (a type of benign thyroid tumor) or focal and diffuse autonomy, which can lead to hyperthyroidism if exposed to high iodine doses
Acute bronchitis
Hypocomplementemic vasculitis (a type of blood vessel inflammation)

Caution is advised for patients with a history of renal failure, tuberculosis, or those taking certain medications like potassium-sparing diuretics or lithium salts, due to the potential for adverse interactions or worsening of underlying conditions. Always consult a healthcare professional before starting treatment, especially if you have an existing medical condition or are taking other prescription or over-the-counter medications.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Iodomarin 200 (Potassium Iodide) documents specific interaction patterns with other medicines, based on both additive physiological effects and procedural interference.

Documented Interaction Patterns

Type of Interacting Product	Officially Documented Outcome	Regulatory Classification
Anti-thyroid Drugs (e.g., Methimazole, Propylthiouracil)	May potentiate the hypothyroid and goitrogenic effects of these co-administered medications.	Pharmacodynamic Interaction
Lithium Preparations	May similarly potentiate the hypothyroid and goitrogenic effects due to additive effects on the thyroid axis.	Pharmacodynamic Interaction
ACE Inhibitors / Potassium-sparing Diuretics	Increased risk of hyperkalemia (elevated serum potassium levels) due to reduced potassium clearance.	Exposure-Altering Interaction

Interaction-Related Restrictions

Co-administration with Angiotensin-Converting Enzyme (ACE) Inhibitors, Potassium-sparing diuretics, and other Potassium-containing medications carries a documented risk of contributing to hyperkalemia and associated cardiac issues. The presence of the iodide component interferes with the thyroidal uptake of radioactive iodine ( I^131), necessitating procedural restriction or contraindication when the radioactive agent is used for diagnostic or therapeutic purposes. This hyperkalemia risk is heightened in patients with impaired renal function.

Mechanism of Action

How Iodomarin 200 Works: Mechanism of Action

Iodomarin 200 provides iodide (I^-), an essential trace element and substrate that initiates the primary biosynthetic pathway for thyroid hormones. The iodide is selectively accumulated in thyroid follicular cells via the sodium-iodide symporter (NIS), a transport protein located on the basal membrane. This active transport is the critical initial step, immediately followed by the oxidation and subsequent incorporation (organification) of iodide into thyroglobulin, the precursor for thyroxine (T4) and triiodothyronine (T3) synthesis.

Restoring sufficient iodide ensures the necessary substrate is available for downstream hormone production. The resulting adequate levels of circulating T4 and T3 engage the negative feedback loop on the Hypothalamic–Pituitary–Thyroid (HPT) axis, leading to the modulation of Thyroid-Stimulating Hormone (TSH) secretion by the pituitary. This adjustment acts to modify the physiological signaling patterns that drive thyroid cell proliferation. T3 further exerts its systemic effect by binding to nuclear receptors, modulating gene transcription and altering expression patterns within metabolic and growth-related pathways.

Dosage and Administration Information

Administration Scope and Routine Use

Iodomarin 200 is administered via the oral route using the tablet dosage form. The standardized pattern requires the tablet to be taken once daily, establishing a consistent, non-intermittent supply of iodide.

The tablet is ingested after a meal and swallowed with a sufficient amount of liquid.

Labeled Dosing Regimens

The standard daily dose for routine prophylaxis and goiter treatment in adults and adolescents is typically 100 to 200 micrograms. The duration of use for prophylaxis is often long-term or permanent, while goiter treatment usually requires a defined course of 6 to 12 months or longer.

Population-Specific Dosing: For patients who are pregnant or lactating, the dose is 200 to 300 micrograms daily to support higher physiological requirements. Pediatric prophylaxis dosing ranges from 50 to 100 micrograms daily.

Special Procedural Conditions

A distinct, high-milligram (mg) dosing regimen for emergency thyroid blocking exists for the active substance, Potassium Iodide. This separate use involves taking doses such as 130 mg; administration is strictly conditional upon and must follow specific situational instructions. In this specific scenario, the milligram tablet may be crushed and mixed with liquids for consumption.

Recent Clinical Evidence

Evidence for Preventing and Managing Goiter

Research into iodine preparations was studied for goiter in populations where dietary iodine intake was observed in insufficient levels. These studies include long-term community intervention studies and prospective controlled trials primarily examining school-aged children and general population groups. Findings describe patterns related to changes in the measured rate of thyroid enlargement and shifts in iodine status biomarkers, such as Urinary Iodine Concentration (UIC). Controlled trials reported data showing patterns related to changes in the incidence of thyroid enlargement. The research pool contains numerous older trials that were not randomized, and evidence quality varies across studies.

Evidence in Pregnancy and Lactation

Iodine supplementation was also evaluated in women who were pregnant or lactating. Research monitored maternal and infant iodine status, thyroid function biomarkers, and the long-term neurocognitive development of the offspring. Studies reported shifts in maternal iodine status and described patterns related to changes in TSH levels in deficient pregnant women. However, findings from studies that focused on populations with mild-to-moderate iodine deficiency have been mixed regarding the impact on specific child neurocognitive scores.

Research Gaps and Follow-up

The sustained status of iodine balance has been observed in community-based studies where follow-up durations extended up to 16 years. For maternal status research, children were monitored for neurocognitive outcomes into early childhood. The evidence base for outcomes related to subtle impairments in cognition in children born to mildly deficient mothers data are still emerging due to a documented lack of good-quality randomized controlled trials. Data for certain groups, such as older adults without thyroid disease, remain insufficient.

Frequently Asked Questions (FAQ)

Common questions about Iodomarin 200 (FAQ)

Q: What is the actual main purpose of Iodomarin 200?

According to official regulatory documents, the primary labeled purpose of Iodomarin 200 is twofold: the prevention of iodine deficiency (prophylaxis) and the treatment of goiter (an enlargement of the thyroid gland) that is caused by iodine deficiency. This classification relates to its use in specific populations with inadequate iodine intake.

Q: Is Iodomarin 200 generally appropriate for use during pregnancy or breastfeeding?

Official regulatory information describes specific, increased labeled doses for individuals who are pregnant or lactating. This adjusted dosing is established to support the body's higher physiological requirements for iodide during these periods.

Q: Is there any research that examines Iodomarin 200 use in children?

Yes, regulatory documents note that specific pediatric prophylaxis dosing is established for children. Furthermore, research studies supporting the drug's use often include data collected from school-aged children to examine changes in goiter rates.

Q: What official research evidence themes support the use of Iodomarin 200?

Official research themes relate to outcomes observed in populations with iodine deficiency. These include descriptions of positive changes in the rate of thyroid enlargement (goiter reduction) and shifts in key iodine status biomarkers (like Urinary Iodine Concentration). Studies in pregnant women also focus on maternal and infant status.

Q: Is it possible for Iodomarin 200 to cause or worsen existing hyperthyroidism?

Official safety information states that use of this medicine is contraindicated (not allowed) in individuals who have manifest hyperthyroidism or a toxic thyroid adenoma. Regulatory texts also indicate that the risk of developing iodine-induced hyperthyroidism is higher in older patients and individuals with specific thyroid conditions.

Q: Why do some people confuse Iodomarin 200 with the emergency radiation-blocking drug?

This confusion arises because Potassium Iodide is the active substance in both the daily microgram-dose products (200 mug) and the distinct, high-milligram-dose tablets (e.g., 130 mg) used for emergency thyroid blocking by public health authorities. They share the same active ingredient but have different concentrations and completely different medical uses.

Q: What is the difference in efficacy between the 100 mcg and 200 mcg formulations, according to research?

Regulatory documents list both 100 mug and 200 mug, which are both within the established regulatory range for adult prophylaxis. However, there is no specific statement available in the official product information that focuses on the comparative efficacy solely between these two microgram doses.

Q: Is Iodomarin 200 a vitamin or a medication?

Iodomarin 200 is classified as a medicinal product (drug) by regulatory bodies. It has specific regulatory approvals for the treatment and prophylaxis of medical conditions related to iodine deficiency, which differs from the classification of a general dietary supplement or vitamin.

Q: Is Iodomarin 200 the same as potassium iodide?

Yes, Potassium Iodide is the pharmaceutical name for the active substance contained within the Iodomarin 200 product. The name Iodomarin 200 refers to the commercial preparation containing the active substance at the 200 mug strength.

Q: Is Iodomarin 200 considered a long-term or short-term treatment?

Official information describes use for the prevention of iodine deficiency (prophylaxis) as often being long-term or permanent. In contrast, the treatment of existing goiter typically requires a defined course of 6 to 12 months or longer.

Q: Are there any common misuses of Iodomarin 200 that people should be aware of?

Official warnings describe a risk of adverse effects, including the potential for iodine-induced hyperthyroidism, if the drug is used by individuals with certain pre-existing thyroid conditions (contraindications). Risks are also linked to prolonged high-dose exposure in susceptible patients.

Q: Can Iodomarin 200 cause weight gain?

Weight gain is not listed as a direct common side effect. However, it is noted in some product information as a potential sign of developing low thyroid levels (hypothyroidism), which is a rare adverse effect that may occur with iodide use.

Q: Is it common for people to feel nauseous when they first start taking Iodomarin 200?

Gastrointestinal symptoms like nausea, vomiting, and stomach pain are described in regulatory documents as possible or common side effects associated with potassium iodide preparations.

Q: What are the most serious side effects described in official drug documentation?

The most serious adverse reactions described in official regulatory texts include severe hypersensitivity reactions, such as Angioedema (swelling of the face, throat, or tongue). Other serious, rare effects include severe iodine-induced hypothyroidism or hyperthyroidism.

Q: What common foods or beverages are described as interacting with Iodomarin 200?

Official product information notes that taking the medicine after a meal or with food or milk may help to improve the taste and lessen the likelihood of stomach upset. There are no specific common foods listed that must be avoided entirely.

Q: If I miss a dose of Iodomarin 200, what does the product information generally say to do?

Product information generally suggests taking a missed dose as soon as possible. However, if it is almost time for the next scheduled dose, the product information states that the missed dose should generally be skipped and the patient should return to the regular schedule. Official information advises against taking a double dose to compensate for a forgotten dose.

Q: What happens if someone accidentally takes too much Iodomarin 200?

Regulatory information states that seeking medical help immediately or contacting a Poison Control Center is advised in case of overdose. Taking more than the recommended amount can increase the chance of experiencing side effects.

Q: Can Iodomarin 200 affect the results of thyroid function tests?

Yes, the iodide component is documented to interfere with the thyroidal uptake of radioactive iodine, which is used in certain diagnostic tests. Additionally, the drug can cause transient changes in blood levels of hormones like TSH, T4, and T3 in some patients.

Q: Can Iodomarin 200 cause changes in mood or sleep?

Changes in mood and sleep (e.g., trouble sleeping) are listed in some official information as potential signs of developing thyroid problems (both hyper- and hypothyroidism). These are rare adverse effects associated with iodide use.

Q: Is there a link between Iodomarin 200 and hair loss?

Hair loss is not listed as a direct common side effect. However, it is noted in some regulatory information as a potential sign of developing low thyroid levels (hypothyroidism), which is a rare adverse effect that may occur with iodide use.

Q: Is Iodomarin 200 effective for preventing a condition or only for treating an existing one?

Official labeling defines its purpose for both the prevention of iodine deficiency (prophylaxis) and the treatment of iodine deficiency goiter (an existing condition).

Q: What should a patient do if they suspect an allergic reaction to Iodomarin 200?

Official information advises that if symptoms of an allergic reaction occur, such as a rash, localized swelling, or trouble breathing, immediate discontinuation of the drug is recommended, and seeking medical help right away (e.g., calling for emergency medical assistance) is necessary.

Q: How does Iodomarin 200 affect people with autoimmune diseases, like Hashimoto's?

Official information notes that the inhibitory effect of pharmacologic iodine on the thyroid can be exacerbated (made worse) in patients with conditions like Hashimoto's thyroiditis, where the thyroid's natural regulation of iodine is already abnormal.

Q: Do health bodies mandate regular testing (blood tests) while a patient is using Iodomarin 200?

Regulatory text indicates that a healthcare provider may order certain lab tests to check the body's response to potassium iodide and monitor the patient's thyroid status during treatment.

Q: Is it true that taking Iodomarin 200 with milk can change how it's absorbed?

Product information notes that taking the medicine with milk or juice may help to improve the taste and lessen stomach upset. This is a patient comfort recommendation and is not described as altering the primary absorption.

Q: Why is the dosage different for different age groups in some official documents?

Dosage is adjusted across different populations (such as pediatrics, or pregnant/lactating individuals) to support either the standardized daily requirement for each age group or to support higher physiological requirements, as is the case during pregnancy.

How should Iodomarin 200 be stored and disposed of?

How to Store and Dispose of Iodomarin 200

The storage and disposal of Iodomarin 200 tablets are strictly defined by regulatory requirements to maintain product integrity and ensure safety.

Official Storage Conditions

Iodomarin 200 must be kept in its original container, which should be tightly closed. The tablets require storage at a controlled room temperature, typically +5 C to +25 C.

Protection: The product must be protected from light, direct sunlight, and moisture to prevent degradation. Excess heat and storage in damp areas must be avoided.
Child Safety: The medication must be kept strictly out of the sight and reach of children and pets.

Stability and Disposal

The tablets must not be used after the expiry date printed on the packaging. If a liquid mixture is prepared from the tablet, it is only stable when refrigerated for a maximum of 7 days.

Disposal Rule: Unused or expired tablets should be discarded in the household trash after being mixed with an unappealing substance. Do not flush the medicine down the toilet or pour it into any drain.

Iodomarin 200